Using a large cohort of UK residents (UK Biobank), we explored the clinical and economic value of LBTs (bilirubin, albumin, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transferase) and urate in lung cancer risk prediction. This evidence concerns the gene ALB and lung cancer.